Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3869.69 | 578 / 578 | 90% | 12.41 | 1041 / 1155 |
thymus | 78% | 694.36 | 509 / 653 | 79% | 20.63 | 480 / 605 |
prostate | 75% | 456.47 | 183 / 245 | 74% | 3.98 | 370 / 502 |
breast | 67% | 331.02 | 306 / 459 | 72% | 4.05 | 805 / 1118 |
bladder | 67% | 504.19 | 14 / 21 | 59% | 4.80 | 295 / 504 |
intestine | 62% | 816.30 | 600 / 966 | 63% | 3.90 | 331 / 527 |
stomach | 53% | 289.68 | 192 / 359 | 70% | 4.37 | 200 / 286 |
kidney | 48% | 354.70 | 43 / 89 | 69% | 4.73 | 623 / 901 |
esophagus | 42% | 222.69 | 607 / 1445 | 68% | 3.54 | 124 / 183 |
skin | 33% | 139.42 | 601 / 1809 | 67% | 5.72 | 318 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 59.64 | 29 / 29 |
peripheral blood | 100% | 18470.37 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 6416.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 8.90 | 42 / 45 |
uterus | 28% | 119.78 | 48 / 170 | 63% | 3.50 | 288 / 459 |
pancreas | 10% | 46.51 | 33 / 328 | 75% | 4.92 | 134 / 178 |
adipose | 84% | 593.06 | 1009 / 1204 | 0% | 0 | 0 / 0 |
liver | 51% | 238.26 | 115 / 226 | 24% | 1.19 | 97 / 406 |
ovary | 9% | 36.70 | 16 / 180 | 51% | 2.04 | 220 / 430 |
adrenal gland | 47% | 206.23 | 121 / 258 | 9% | 0.32 | 20 / 230 |
blood vessel | 43% | 331.30 | 570 / 1335 | 0% | 0 | 0 / 0 |
brain | 11% | 69.62 | 297 / 2642 | 24% | 1.30 | 171 / 705 |
heart | 25% | 121.75 | 216 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 25% | 1.16 | 20 / 80 |
muscle | 1% | 5.07 | 12 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031589 | Biological process | cell-substrate adhesion |
GO_0006897 | Biological process | endocytosis |
GO_0030048 | Biological process | actin filament-based movement |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0006887 | Biological process | exocytosis |
GO_0007015 | Biological process | actin filament organization |
GO_0002456 | Biological process | T cell mediated immunity |
GO_0072678 | Biological process | T cell migration |
GO_0120117 | Biological process | T cell meandering migration |
GO_0071976 | Biological process | cell gliding |
GO_0038096 | Biological process | Fc-gamma receptor signaling pathway involved in phagocytosis |
GO_0005902 | Cellular component | microvillus |
GO_0031256 | Cellular component | leading edge membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030175 | Cellular component | filopodium |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0001891 | Cellular component | phagocytic cup |
GO_0005737 | Cellular component | cytoplasm |
GO_0030027 | Cellular component | lamellipodium |
GO_0016459 | Cellular component | myosin complex |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0043325 | Molecular function | phosphatidylinositol-3,4-bisphosphate binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0000146 | Molecular function | microfilament motor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005516 | Molecular function | calmodulin binding |
Gene name | MYO1G |
Protein name | Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2 (mHag HA-2)] Myosin IG |
Synonyms | HA2 |
Description | FUNCTION: Unconventional myosin required during immune response for detection of rare antigen-presenting cells by regulating T-cell migration. Unconventional myosins are actin-based motor molecules with ATPase activity and serve in intracellular movements. Acts as a regulator of T-cell migration by generating membrane tension, enforcing cell-intrinsic meandering search, thereby enhancing detection of rare antigens during lymph-node surveillance, enabling pathogen eradication. Also required in B-cells, where it regulates different membrane/cytoskeleton-dependent processes. Involved in Fc-gamma receptor (Fc-gamma-R) phagocytosis. .; FUNCTION: [Minor histocompatibility antigen HA-2]: Constitutes the minor histocompatibility antigen HA-2. More generally, minor histocompatibility antigens (mHags) refer to immunogenic peptide which, when complexed with MHC, can generate an immune response after recognition by specific T-cells. The peptides are derived from polymorphic intracellular proteins, which are cleaved by normal pathways of antigen processing. The binding of these peptides to MHC class I or class II molecules and their expression on the cell surface can stimulate T-cell responses and thereby trigger graft rejection or graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation from HLA-identical sibling donor. GVHD is a frequent complication after bone marrow transplantation (BMT), due to mismatch of minor histocompatibility antigen in HLA-matched sibling marrow transplants. HA-2 is restricted to MHC class I HLA-A*0201. . |
Accessions | F8WAS7 B0I1T2 F8WEW9 A0A3B3IU30 ENST00000648014.1 ENST00000258787.12 [B0I1T2-1] ENST00000464434.1 ENST00000495831.5 |